Nonetheless, the clinical significance of CD151 expression shows that CD151 has great potential to be developed as a diagnostic biomarker which may be helpful for early detection or screening, or as a prognostic biomarker given its relevance in predicting lung cancer or asthma severity. This evidence concerns the gene CD151 and lung carcinoma.